A Genome‐Wide Survey of DNA Methylation Status in Whole Blood of Patients With Hidradenitis Suppurativa Suggests Systemic Immune Dysregulation and Systemic Disease Burden
Experimental Dermatology · 2025
DOI: 10.1111/exd.70065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Marco Montoya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beth Israel Deaconess Medical Center, Department of Dermatology, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: DNA Methylation, Hidradenitis Suppurativa. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Department of Dermatology Stern Grant from Beth Israel Deaconess Medical Center.
Abstract (Originalsprache)
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a significant systemic disease burden. In this study, we profiled and compared the DNA methylation patterns in whole blood of HS patients versus control subjects to identify associated genes and biological pathways enriched in HS patients that may explain the systemic immune dysregulation observed in these patients. Using the Illumina 850 methylation BeadChip array, we measured the genome‐wide DNA methylation status of each subject and identified 16 variably methylated probes (VMPs) between control subjects and HS patients ( p adj < 0.05). These VMPs were associated with genes that regulate immune responses (e.g. DEFB104B , GRAMD4 ) and drive the risk of malignancy (e.g. BCR , RNF4 ). Additionally, they annotated to downstream biological pathways that regulate both innate and adaptive immunity, including the interferon gamma signalling pathway. Taken together, our results suggest a potential role of epigenetics in regulating the expression of immune‐regulatory/tumour suppressor genes in the systemic circulation of HS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beth Israel Deaconess Medical Center, Department of Dermatology, Boston, Massachusetts, USA.
- Data Science Learning, AstraZeneca, Gothenberg, Sweden.
- Harvard Medical School, Boston, Massachusetts, USA.
Förderung
- Department of Dermatology Stern Grant from Beth Israel Deaconess Medical Center
Zitieren
APA
Montoya, M., Khetani, R., Martinez, R., Mayur, O., Yi, J. Z., & McGee, J. S. (2025). A Genome‐Wide Survey of DNA Methylation Status in Whole Blood of Patients With Hidradenitis Suppurativa Suggests Systemic Immune Dysregulation and Systemic Disease Burden. Experimental Dermatology. https://doi.org/10.1111/exd.70065
Vancouver
Montoya M, Khetani R, Martinez R, Mayur O, Yi JZ, McGee JS. A Genome‐Wide Survey of DNA Methylation Status in Whole Blood of Patients With Hidradenitis Suppurativa Suggests Systemic Immune Dysregulation and Systemic Disease Burden. Experimental Dermatology. 2025. doi:10.1111/exd.70065
BibTeX
@article{Montoya2025,
author = {Montoya, Marco and Khetani, Radhika and Martinez, Rebeca and Mayur, Omkar and Yi, Julie Z and McGee, Jean S},
title = {A Genome‐Wide Survey of DNA Methylation Status in Whole Blood of Patients With Hidradenitis Suppurativa Suggests Systemic Immune Dysregulation and Systemic Disease Burden},
journal = {Experimental Dermatology},
year = {2025},
doi = {10.1111/exd.70065}
}
EUVIMED